Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 3/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18485435 | 1.00 | TSHR (0.37) | TSHRMAPK1POLBCYP3A4NPSR1 | |
| SCHEMBL18485441 | 0.83 | HTT (0.40) | TSHRPOLBCYP3A4NPSR1ALDH1A1 | |
| SCHEMBL5569659 | 0.80 | KMT2A (0.44) | TSHRPOLBNPSR1ALDH1A1ATM | |
| SCHEMBL18485469 | 0.76 | LMNA (0.40) | TSHRNPSR1ALDH1A1ATMCA12 | |
| SCHEMBL8521913 | 0.73 | CYP3A4 (0.43) | TSHRMAPK1CYP3A4NPSR1ALDH1A1 | |
| SCHEMBL18485419 | 0.73 | CYP3A4 (0.39) | TSHRMAPK1CYP3A4NPSR1ALDH1A1 | |
| SCHEMBL28108459 | 0.72 | FAAH (0.33) | MAPK1CYP3A4NPSR1FAAHMGLL | |
| SCHEMBL23812541 | 0.70 | NPSR1 (0.40) | TSHRMAPK1CYP3A4NPSR1ALDH1A1 | |
| SCHEMBL6831925 | 0.69 | BCHE (0.41) | TSHRMAPK1CYP3A4NPSR1ALDH1A1 | |
| SCHEMBL10768629 | 0.68 | NPSR1 (0.63) | TSHRMAPK1POLBCYP3A4NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6749990-B2 | UNSATURATED HALOGENATED HYDROCARBON AS PHOTORESIST MONOMER, FOR EXAMPLE 3,3,4,4,5,5,6,6,6-NONAFLUORO-1-HEXENE; ETCHING RESISTANCE, HEAT RESISTANCE AND ADHESIVENESS, AND IS DEVELOPABLE IN AQUEOUS TETRAMETHYLAMMONIUM HYDROXIDE | HYNIX SEMICONDUCTOR INC. (KR) | 2004-06-15 | — | — | US | disclosed |
| US-20030017404-A1 | Chemical amplification photoresist monomers, polymers therefrom and photoresist compositions containing the same | HYNIX SEMICONDUCTOR INC. (KR) | 2003-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030017404-A1 | Chemical amplification photoresist monomers, polymers therefrom and photoresist compositions containing the same | ETV6, UFM1, UTS2R | TSHR 1899/4885MAPK1 1318/4885POLB 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.